ArticleAmerican journal of cancer research2025

STOML2 inhibits sorafenib-induced ferroptosis in hepatocellular carcinoma via p-AKT signaling pathway.

Ruiqi Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.